pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,971 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: earnings×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT07398586: The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis

    Sponsor: Second Affiliated Hospital of Wenzhou Medical University. Phase: PHASE4. Conditions: Ulcerative Colitis (UC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483073: A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

    Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Colitis, Ulcerative, Crohn Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07147569: TAMBE Japan Post-Marketing Surveillance

    Sponsor: W.L.Gore & Associates. Phase: . Conditions: Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07007169: Mediterranean Diet and Inequality in Early Breast Cancer

    Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark. Phase: PHASE2. Conditions: Early Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07352683: Open TAP-block in Pediatric Abdominal Surgery

    Sponsor: Uppsala University. Phase: NA. Conditions: Pain Management After Surgery

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT03580083: RGX-111 Gene Therapy in Patients With MPS I

    Sponsor: REGENXBIO Inc.. Phase: PHASE1. Conditions: Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04106466: DBS for TRD With the Medtronic Summit RC+S

    Sponsor: Helen Mayberg, MD. Phase: NA. Conditions: Major Depressive Disorder, Treatment Resistant Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05492422: Central Executive Training and Parent Training for ADHD

    Sponsor: Florida State University. Phase: NA. Conditions: ADHD

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04370522: Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer

    Sponsor: Spanish Breast Cancer Research Group. Phase: . Conditions: Metastatic Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03920722: Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Microscopic Polyangiitis (MPA)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07502729: Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding

    Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Portal Hypertension, Gastroesophageal Varices Hemorrhage, Gastric Varices, Esophageal Varices

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT03123029: Expanded Access to Venetoclax

    Sponsor: AbbVie. Phase: . Conditions: Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia (ALL), Amyloidosis, Plasma Cell Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07411924: Mastication, Cognition, and Nutritional Status in Multiple Sclerosis

    Sponsor: Ondokuz Mayıs University. Phase: . Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06564623: Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

    Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE1. Conditions: Biliary Tract Cancers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07524023: Emotional-distress-based Integrated Care Programme in Patients With Stable COPD

    Sponsor: University of Zurich. Phase: NA. Conditions: COPD, COPD (Chronic Obstructive Pulmonary Disease)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04702880: A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

    Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Extensive-stage Small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001979: Immune System Related Kidney Disease

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Kidney Disease, Nephrotic Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06681246: The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment

    Sponsor: Weizmann Institute of Science. Phase: NA. Conditions: Obesity, Weight Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00582296: Multi-Organ Screening Recommendations in Patients With Lynch Syndrome

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Lynch Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05362903: A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

    Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Hypercholesterolemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07413042: A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

    Sponsor: Peking University Cancer Hospital & Institute. Phase: PHASE1. Conditions: SCLC, Extensive Stage

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05932342: Improving Cognition of Older Adults in Community Housing

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Aging, Mental Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07218770: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Active Noninfectious Uveitis Affecting the Posterior Segment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07469969: Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Training Therapy for Chronic Subjective Tinnitus

    Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: NA. Conditions: Chronic Subjective Tinnitus

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05979441: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

    Sponsor: argenx. Phase: PHASE3. Conditions: Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05302583: Aromatherapy Inhaler Use for HSCT Distress

    Sponsor: Stanford University. Phase: NA. Conditions: Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant, Aromatherapy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03648905: Clinical Laboratory Evaluation of Chronic Autonomic Failure

    Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Parkinson's Disease, Multiple System Atrophy, Autonomic Failure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06642805: Bilio-pancreatic Complications of Congenital Duodenal Obstructions

    Sponsor: University Hospital, Angers. Phase: . Conditions: Duodenal Obstruction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06752356: A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Sponsor: Kedrion S.p.A.. Phase: PHASE3. Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06265051: Tirofiban After Successful MT Recanalization in AIS

    Sponsor: Xiang Luo. Phase: PHASE2. Conditions: Acute Ischemic Stroke, Vessel Occlusion

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06553131: Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison

    Sponsor: Loma Linda University. Phase: . Conditions: Neuromuscular Blockade

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07539129: Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Acne Vulgaris

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04644029: Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07320053: Effect of Longitudinal Care in Primary Health Care: An Analysis From the Patient's Perspective

    Sponsor: IBS Granada. Phase: . Conditions: Age 65 and Older, Polypharmacy, Cronic Lung Disease, Mental Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06854653: A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

    Sponsor: Prescient Therapeutics, Ltd.. Phase: PHASE2. Conditions: CTCL

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07227337: Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Post Traumatic Stress Disorder, Depression, Violence

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04021537: Non-invasive Nerve Stimulation and Sleep

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07614672: Effects Of Instrument Assisted Soft Tissue Mobilization as Compared With Manual Longitudinal Friction Massage in Individuals With Plantar Fasciitis.

    Sponsor: Ibadat International University, Islamabad. Phase: NA. Conditions: Plantar Fasciitis of Both Feet

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07052253: A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

    Sponsor: Akeso. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07310953: Clinical Utility of the Numerical Verbal Scale (NVS) and the Pain and Functional Activity Scale (PFAS) in the Management of Rescue Analgesia in Acute Postoperative Pain. Randomized Study.

    Sponsor: Fundacin Biomedica Galicia Sur. Phase: NA. Conditions: Analgesia, Post Operative Pain, Acute Pain, Functional; Anesthesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06135753: Psychosomatic Intervention in Fibromyalgia.

    Sponsor: University of Florence. Phase: NA. Conditions: Fibromyalgia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03384537: Antimicrobial Effect of Tropolone Containing Versus Tropolone Free Mouthwash

    Sponsor: Cairo University. Phase: EARLY_PHASE1. Conditions: Dental Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07404345: Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)

    Sponsor: Hospital Civil de Guadalajara. Phase: PHASE4. Conditions: Hemodialysis Access Failure, Kidney Disease, End-Stage, Hemodialysis Catheter

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07536139: COMPARATIVE EFFICACY OF ELECTROMAGNETIC FIELD THERAPY AND TIBIAL NERVE STIMULATION IN URGE URINARY INCONTINENCE

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: NA. Conditions: Urge Urinary Incontinence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07462039: Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing

    Sponsor: Eastern Mediterranean University. Phase: NA. Conditions: Nurse's Role, Pain Management, Cervical Cancer Screening, Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07555639: An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: NA. Conditions: Colon Cancer, Breast Cancer, Ovarian Cancer, Genetic Risk Factors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06737432: Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.

    Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Ventilation, ARDS, Respiratory Failure, Mechanical Ventilation, Ventilator-induced Lung Injury (VILI), Quality Improvement, Ventilator Associated Events

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05499832: Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE3. Conditions: Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07205198: A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

    Sponsor: Shanghai Institute Of Biological Products. Phase: PHASE1. Conditions: Advanced Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06321198: A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

    Sponsor: Anhui Provincial Hospital. Phase: NA. Conditions: Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

    full page →ctgov ↗
    ← prev
    page 48 of 100
    next →